Functions, divergence and clinical value of TAp73 isoforms in cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F13%3A%230000403" target="_blank" >RIV/00209805:_____/13:#0000403 - isvavai.cz</a>
Result on the web
<a href="http://link.springer.com/article/10.1007/s10555-013-9424-x" target="_blank" >http://link.springer.com/article/10.1007/s10555-013-9424-x</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s10555-013-9424-x" target="_blank" >10.1007/s10555-013-9424-x</a>
Alternative languages
Result language
angličtina
Original language name
Functions, divergence and clinical value of TAp73 isoforms in cancer
Original language description
The p73 gene encodes the tumour suppressive full-length TAp73 and N-terminal-truncated DNp73 isoforms that act as dominant negative inhibitors of TAp73. The overall effect of p73 in oncogenesis is thought to depend on the TAp73 to DNp73 isoforms' ratio.TAp73 isoforms include a number of C-terminal variants as a result of alternative splicing in 3'-end. TAp73 isoforms protect cells from oncogenic alterations in a multifaceted way since they are implicated in the suppression of all demonstrated hallmarksand enabling characteristics of cancer. Their best established role is in apoptosis, a process which seems to be differently affected by each TAp73 C-terminal variant. Based on previous findings and our thorough bioinformatics analysis, we highlight that TAp73 variants are functionally non-equivalent, since they present major differences in their transactivation efficiencies, protein interactions, response to DNA damage and apoptotic effects that are attributable to the primary structur
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cancer Metastasis Reviews
ISSN
0167-7659
e-ISSN
—
Volume of the periodical
32
Issue of the periodical within the volume
3-4
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
24
Pages from-to
511-534
UT code for WoS article
000327845700016
EID of the result in the Scopus database
—